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vasopressor-dependent cardiovascular
surgery patients
Shinjiro Saito1*, Shigehiko Uchino1, Masanori Takinami1, Shoichi Uezono1 and Rinaldo Bellomo2
Abstract
Background: In vasopressor-dependent patients who had undergone cardiovascular surgery, we examined
whether those with progression of acute kidney injury (AKI) had a greater difference (deficit) between premorbid
and within-ICU hemodynamic pressure-related parameters compared to those without AKI progression.
Methods: We assessed consecutive adults who underwent cardiovascular surgery and who stayed in our ICU
for at least 48 hours and received vasopressor support for more than 4 hours. We obtained premorbid and
vasopressor-associated, time-weighted average values for hemodynamic pressure-related parameters (systolic
[SAP], diastolic [DAP], and mean arterial pressure [MAP]; central venous pressure [CVP], mean perfusion pressure
[MPP], and diastolic perfusion pressure [DPP]) and calculated deficits in those values. We defined AKI progression
as an increase of at least one Kidney Disease: Improving Global Outcomes stage.
Results: We screened 159 patients who satisfied the inclusion criteria and identified 76 eligible patients. Thirty-six
patients (47 %) had AKI progression. All achieved pressure-related values were similar between patients with or
without AKI progression. However, deficits in DAP (P = 0.027), MPP (P = 0.023), and DPP (P = 0.002) were significantly
greater in patients with AKI progression.
Conclusions: Patients with AKI progression had greater DAP, MPP, and DPP deficits compared to patients without AKI
progression. Such deficits might be modifiable risk factors for the prevention of AKI progression.
Keywords: Blood pressure, Acute kidney injury, Blood pressure target, Relative hypotension, Perfusion pressure,
Critical care
Background
Blood pressure (BP) is an important determinant of renal
perfusion. Therefore, achieving optimal BP in vasopressor-
dependent patients is considered important for preventing
the progression of acute kidney injury (AKI). Although
international consensus guidelines recommend adjusting
BP targets according to premorbid BP [1], there are
limited studies investigating the putative benefits of
adjusting BP targets according to premorbid levels in
the clinical setting.
A recent multicenter randomized control trial showed
no significant difference in mortality outcome in pa-
tients with septic shock undergoing resuscitation with a
mean arterial pressure (MAP) target of either 80 mm
Hg to 85 mm Hg (high-target group) or 65 mm Hg to
70 mm Hg (low-target group) [2]. However, that study
also showed that patients with chronic hypertension in
the high-target group had a lower incidence of AKI or
requirement for renal replacement therapy. An obser-
vational cohort study also investigated mean deficits
between premorbid and actual mean perfusion pressure
(MPP) in vasopressor-dependent patients in the intensive
care unit (ICU) (“relative hypotension”) and reported an
association with subsequent AKI [3]. To our knowledge,
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no other studies have assessed the association of such
relative hypotension and AKI progression in patients who
have undergone cardiovascular surgery and are receiving
vasopressor drugs [4]. In addition, a recent study reported
an association of low diastolic BP and septic AKI [5], but
no studies have investigated the association of relative
diastolic hypotension and AKI progression.
Accordingly, we investigated differences between premor-
bid and achieved hemodynamic parameter levels (systolic
arterial pressure [SAP], diastolic arterial pressure [DAP],
MAP, MPP, and diastolic perfusion pressure [DPP]) in
vasopressor-dependent patients to assess whether pa-
tients with AKI progression had greater pressure deficits
compared to those without AKI progression. We specific-
ally focused on patients who had undergone cardiovascu-
lar surgery and whose premorbid central venous pressure
(CVP) could be estimated accurately according to pre-
operative echocardiography, to enable a more precise
estimate of perfusion pressure.
Methods
We conducted a retrospective observational study in a
20-bed ICU at a university hospital in Tokyo, Japan. The
hospital ethics committee of Jikei University School of
Medicine approved the study protocol, and the need for
informed consent was waived because of the retrospective
design of the study.
Study patients
All patients who were admitted to our ICU between
January 2010 and December 2013 were screened retro-
spectively. Consecutive patients who were 18 years of age
or older, had had cardiovascular surgery, stayed in the ICU
for at least 48 hours, and required vasopressor support for
more than 4 hours were identified from our ICU database.
We excluded patients who were on extracorporeal mem-
brane oxygenation (ECMO) or intra-aortic balloon pump
(IABP), were on long-term chronic dialysis, were readmit-
ted to the ICU during the same hospitalization period, or
required spinal perfusion pressure-guided therapy to pre-
vent spinal cord ischemia [6].
Premorbid baseline hemodynamic parameters
We collected three recent BP values measured in the
outpatient clinic. If the number of BP values was insuffi-
cient (less than three), we used BP values noted on the
ward charts before surgery for elective cases. BP values
were excluded if there was any significant escalation of
antihypertensive or diuretic therapy before BP measure-
ments or any acute renal impairment during the period
of BP observations.
Premorbid baseline BP was defined as the mean of the
three recent values. MAP was estimated from SAP and
DAP as DAP + (SAP–DAP)/3. Premorbid baseline CVP
was estimated using inferior vena cava (IVC) parameters
(diameter and collapse) derived from outpatient echo-
cardiography examinations, according to the criteria
recommended by the 2010 American Society of Echo-
cardiography guidelines [7]: the IVC diameter 2.1 cm
or less and collapse more than 50 % correlates with
CVP (mean right atrial pressure) of 3 mmHg, the IVC
diameter 2.1 cm or less with collapse 50 % or less or IVC
diameter more than 2.1 cm with collapse more than 50 %
correlates with CVP of 8 mmHg, and the IVC diameter
more than 2.1 cm and collapse 50 % or less correlates with
CVP of 15 mmHg. Premorbid baseline DPP and MPP
were calculated from premorbid baseline DAP and MAP
and estimated CVP values (DPP =DAP–CVP; MPP =
MAP–CVP). We do not have a formal protocol for a
target MAP for management of patients with shock, but
we usually aim for a target MAP of 65 or 70 mmHg.
Other study variables
We defined T0 as the time when vasopressor support
was started. We collected SAP, DAP, MAP, and CVP
values every 15 minutes, extracted from the patient infor-
mation system (PIMS®, Philips Respironics, Tokyo, Japan).
MPP and DPP were calculated for each data point. These
data were collected from T0 until 72 hours later or until
the time vasopressor support was stopped. We derived
time-weighted average (TWA) values during vasopressor
support from collected data for each patient. TWA was
calculated as follows:
TWA ¼ t1X1 þ t2X2 þ…þ tnXnð Þ= t1 þ t2 þ…þ tnð Þ
where Xn is the value of the variable of interest during
the nth interval, and tn is the duration of the n
th interval.
The percent deficit in TWA parameters in relation to
baseline parameters was determined as % parameter
deficit. For example, we calculated %MPP deficit as
(achieved MPP– baseline MPP)/baseline MPP.
We used the Kidney Disease: Improving Global Out-
comes (KDIGO) creatinine and urine output criteria for
staging and definition of AKI [8]. Changes in serum
creatinine were compared to the premorbid creatinine
level, which was defined as the latest value before oper-
ation. KDIGO stage changes from T0 were assessed
during the initial 72 hours. We defined an increase of at
least one KDIGO stage from T0 as progression of AKI
(AKI+) and no KDIGO stage change as no progression
of AKI (AKI–). TWA vasopressor rates were derived
from noradrenaline infusion rates because our ICU
uses noradrenaline almost exclusively for vasopressor
therapy. In rare cases of profound shock refractory to
high-dose noradrenaline, vasopressin was used.
We collected demographic data (age, sex, body weight,
baseline creatinine level), along with data regarding pre-
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ICU use of antihypertensive drugs, mechanical ventilation,
Acute Physiology and Chronic Health Evaluation (APA-
CHE) II score [9], Sepsis-related Organ Failure Assess-
ment (SOFA) score [10] on the day when vasopressor
support was started, serum lactate level at T0, mixed
venous oxygen saturation (SvO2) and cardiac index at T0,
admission type, surgery type, intraoperative information
(duration of operation, blood loss, fluid balance), use of
vasopressin, exposure of nephrotoxic drugs, and ICU and
hospital lengths of stay. Surgery type was categorized as
cardiac surgery or vascular surgery. Coronary artery
bypass graft and surgery using cardiopulmonary bypass
(valve repair, thoracic aorta aneurysm, or other) was
categorized as cardiac surgery. Aortic surgery without
cardiopulmonary bypass, which included both open re-
pair and endovascular repair, was categorized as vascu-
lar surgery.
Statistical analysis
We compared hemodynamic parameters and other vari-
ables between the AKI+ group and the AKI– group.
Quantitative parameters were reported as median and
interquartile range (25th to 75th percentile) and were
compared using the Mann-Whitney U test. Qualita-
tive parameters were expressed as number and per-
centage and were compared using the chi-square test
or Fisher exact test, as appropriate. A P value of less
than 0.05 was considered statistically significant. A
commercially available statistical package (SPSS 19.0,
IBM Corp., Armonk, NY, USA) was used for all
statistical analyses.
Results
A total of 7,814 consecutive adult patients were admit-
ted to our ICU between January 2010 and December
2013. We screened 159 patients who satisfied the inclu-
sion criteria and identified 76 eligible patients (Fig. 1).
Table 1 lists demographic and clinical characteristics of
these patients. Thirty-six patients (47 %) had an increase
of at least one KDIGO stage from T0 to 72 hours (AKI+
group). Baseline creatinine level was higher in the AKI+
group (0.88 mg/dL vs. 1.07 mg/dL; P = 0.018). Surgery
types were similar between the AKI+ and AKI– groups
(P = 0.373). Fifty-one patients (all cardiac surgery) had a
pulmonary artery catheter. Cardiac index (2.6 L/min/
m2vs. 2.7 L/min/m2, P = 0.593) and SvO2 (67 % vs.
72 %, P = 0.269) were similar between the two groups.
Table 2 lists comparisons of hemodynamic baseline
values and values achieved during vasopressor support
between the AKI+ and AKI– groups. Data on premorbid
BP were from measurements made in the outpatient
clinic (83 % of BP values) and in the ward before elective
operation (17 % of BP values). Overall, the median time
on vasopressor therapy was 1.3 days, and the TWA nor-
adrenaline rate was 0.08 μg/kg/minute. Patients in the
AKI+ group had higher baseline MPP (91 mm Hg vs.
85 mm Hg; P = 0.035), baseline DPP (73 mmHg vs.
67 mmHg; P = 0.047) and lower baseline CVP (P = 0.018).
Both groups achieved similar TWA parameters for all
hemodynamic pressures.
Table 3 lists the AKI stage at T0, maximum AKI stage
and progression during the initial 72 hours and use of
continuous renal replacement therapy (CRRT) during
Fig. 1 Flow chart of study patients. BP blood pressure, CKD chronic kidney disease, CVP central venous pressure, ECMO extracorporeal membrane
oxygenation, IABP intra-aortic balloon pump, ICU intensive care unit, SPP spinal perfusion pressure
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ICU stay. The AKI stage at T0 was similar between the
AKI+ and AKI– groups (P = 0.408). The number of pa-
tients who had maximum AKI progression was 18 (50 %)
on day 1, 14 (39 %) on day 2, and four (11 %) on day 3.
Figure 2 shows % parameter deficits between the AKI+
and AKI– groups, demonstrating that %MAP deficit and
%SAP deficit did not differ between the two groups.
In contrast, %DAP deficit (P = 0.027), %MPP deficit
(P = 0.023) and %DPP deficit (P = 0.002) were significantly
greater in the AKI+ group compared to the AKI– group.
Figure 3 shows hourly changes in %DAP, %MPP, and
%DPP deficits in the AKI+ and AKI– groups. The AKI+
group had consistently greater deficits of all three perfu-
sion pressures in the first 24 hours of vasopressor support
compared with the AKI– group. Overall, 21.7 % and
23.8 % of the %MPP and %DPP deficits, respectively, were
Table 1 Patient characteristics
All patients No KDIGO stage shift (AKI–) ≥1 KDIGO stage shift (AKI+) P value
Number of patients 76 40 36
Age, years 71 (63-77) 69 (62-75) 74 (66-78) 0.057
Male sex 53 (70) 28 (70) 25 (69) 0.958
Weight, kg 61 (52-70) 64 (54-70) 59 (51-67) 0.318
Baseline creatinine, mg/dL 0.92 (0.76-1.13) 0.88 (0.72-1.05) 1.07 (0.84-1.39) 0.018
Antihypertensive drugs 61 (80) 31 (78) 30 (83) 0.523
Emergency surgery 4 (5) 1 (3) 3 (8) 0.255
Cardiac surgery 52 (68) 31 (78) 21 (58) 0.730
Surgery type 0.373
Cardiac surgery
CABG 14 (18) 10 (25) 4 (11)
Valve replacement 21 (28) 13 (33) 8 (22)
TAA 8 (11) 3 (8) 5 (14)
Mixed 7 (9) 4 (10) 3 (8)
Other 2 (3) 1 (3) 1 (3)
Vascular surgery
Open aortic repair 16 (21) 5 (13) 11 (31)
Endovascular aortic repair 8 (11) 4 (10) 4 (11)
Duration of operation, hours 7.08 (6.00-8.68) 7.03 (5.66-8.91) 7.08 (6.00-8.65) 0.992
Intraoperative blood loss, mL 405 (203-841) 373 (143-675) 505 (263-949) 0.080
Intraoperative fluid balance, mL 2750 (2150-5260) 2675 (2146-4650) 2925 (2150-5595) 0.655
Mechanical ventilation 68 (90) 35 (88) 33 (92) 0.555
APACHE II score 16 (12-20) 15 (11-18) 17 (14-21) 0.046
SOFA score total 8 (6-9) 7 (5-9) 8 (7-9) 0.290
Cardiovascular 3 (3-4) 3 (3-4) 3 (3-4) 0.847
Respiratory 1 (1-2) 1 (1-2) 1.5 (1-2) 0.818
Liver 0 (0-1) 0 (0-1) 0 (0-1) 0.554
Renal 0 (0-1) 0 (0-1) 1 (0-1) 0.005
Coagulation 2 (1-2) 2 (1-2) 2 (1-2) 0.527
Central nerves 0 (0-0) 0 (0-0) 0 (0-0) 0.053
Lactate, mmol/L 1.7 (1.1-2.4) 1.6 (1.0-2.2) 1.8 (1.1-2.7) 0.250
Exposed to nephrotoxins in ICU 2 (3) 1 (3) 1 (3) 0.940
ICU length of stay, days 3.8 (2.8-5.8) 3.7 (2.8-5.5) 4.2 (2.8-5.8) 0.240
Hospital length of stay, days 30 (23-39) 31 (23-37) 29 (21-44) 0.750
Hospital mortality 3 (4) 2 (5) 1 (3) 0.619
Quantitative parameters are reported as median (interquartile range; 25th–75th percentile). Qualitative parameters are expressed as number (%)
AKI acute kidney injury, APACHE II Acute Physiology and Chronic Health Evaluation II, CABG coronary artery bypass graft, ICU intensive care unit, KDIGO Kidney
Disease: Improving Global Outcomes, SOFA Sequential Organ Failure Assessment, TAA thoracic aorta aneurysm
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due to an increase in CVP, with no difference between the
AKI+ and AKI– groups.
Discussion
Key findings
We investigated whether, in patients who had undergone
cardiovascular surgery and were receiving vasopressor
support, the time-weighted difference between premorbid
and in-ICU pressure-related parameters (the degree of
relative hypotension) was greater among those who devel-
oped AKI progression compared with those who did not.
We observed that although patients with AKI progression
had equivalent MAP, DAP, and MPP to those who did
not, they had significantly greater DAP, MPP, and DPP
deficits.
Comparison to previous studies
Selection of an effective BP target to manage vasopressor-
dependent patients has been a controversial issue for
decades. With respect to septic shock, a large random-
ized clinical trial (N = 776) compared protocols target-
ing MAPs of either 65 mm Hg to 70 mm Hg or 80 mm
Hg to 85 mm Hg for 5 days and found no significant
difference in mortality [2]. However, chronic hyperten-
sion was reported in 44 % of patients, and in a prede-
fined subgroup analysis of these patients, targeting a
higher MAP was associated with a lower rate of serum
Table 2 Baseline and achieved hemodynamic parameters and variables during vasopressor support
All patients No KDIGO stage shift (AKI–) ≥1 KDIGO stage shift (AKI+) P value
Baseline SAP, mm Hg 130 (120-138) 130 (117-137) 131 (120-142) 0.592
Baseline DAP, mm Hg 74 (67-84) 73 (62-82) 79 (69-85) 0.163
Baseline MAP, mm Hg 92 (86-101) 91 (84-99) 97 (87-103) 0.154
Baseline CVP, mm Hg 3 (3-8) 3 (3-8) 3 (3-8) 0.018
3 mm Hg 48 (63) 21 (53) 27 (75)
8 mm Hg 21 (28) 12 (30) 9 (25)
15 mm Hg 7 (9) 7 (17) 0 (0)
Baseline MPP, mm Hg 89 (82-97) 85 (76-93) 91 (84-99) 0.035
Baseline DPP, mm Hg 70 (63-81) 67 (55-76) 73 (64-81) 0.047
Time on vasopressor, days 1.3 (0.7-2.7) 1.2 (0.7-2.3) 1.4 (0.7-2.8) 0.303
TWA vasopressor rate, μg/kg/min 0.08 (0.04-0.12) 0.08 (0.05-0.12) 0.08 (0.04-0.12) 0.685
Vasopressin 5 (7) 2 (5) 3 (8) 0.558
TWA-SAP achieved, mm Hg 118 (110-128) 115 (107-128) 120 (114-129) 0.170
TWA-DAP achieved, mm Hg 58 (53-62) 58 (54-62) 57 (53-62) 0.803
TWA-MAP achieved, mm Hg 74 (70-78) 73 (70-78) 75 (72-79) 0.323
TWA-CVP achieved, mm Hg 8.0 (5.7-9.6) 7.7 (5.6-9.4) 8.6 (5.8-9.7) 0.344
TWA-MPP achieved, mm Hg 66 (62-70) 65 (61-70) 67 (63-71) 0.533
TWA-DPP achieved, mm Hg 50 (46-53) 50 (47-54) 50 (46-54) 0.892
Quantitative parameters are reported as median (interquartile range; 25th–75th percentile). Qualitative parameters are expressed as number (%)
AKI acute kidney injury, CVP central venous pressure, DAP diastolic arterial pressure, DPP diastolic perfusion pressure, KDIGO Kidney Disease: Improving Global
Outcomes, MAP mean arterial pressure, MPP mean perfusion pressure, SAP systolic arterial pressure, TWA time-weighted average
Table 3 Staging of AKI





AKI stage at T0 0.408
No AKI 66 (87) 33 (83) 33 (92)
Stage 1 5 (7) 4 (10) 1 (3)




No AKI 33 (43) 33 (83) 0 (0)
Stage 1 24 (32) 4 (10) 20 (56)
Stage 2 11 (15) 3 (8) 8 (22)




No change 40 (53) 40 (100) 0 (0)
One stage 23 (30) 0 (0) 23 (64)
Two stages 7 (9) 0 (0) 7 (19)
Three stages 6 (8) 0 (0) 6 (17)
CRRT during ICU
stay
5 (7) 1 (3) 4 (11) 0.131
Qualitative parameters are expressed as number (%)
AKI acute kidney injury, CRRT continuous renal replacement therapy,
ICU intensive care unit, KDIGO Kidney Disease: Improving Global Outcomes,
T0 the time when vasopressor support was started
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creatinine doubling and renal replacement therapy re-
quirement. A recent review of data related to MAP tar-
gets in septic shock identified seven comparative studies
and suggested that a MAP target of 65 mm Hg is usually
sufficient in patients with septic shock, but a MAP of
approximately 75 mm Hg to 85 mm Hg may prevent AKI
development in patients with chronic hypertension [11].
Fewer studies exist for types of shock other than septic
shock. In a case-control study in noncritically ill ward
patients, those who developed AKI were more likely to
have had relative hypotension than control patients
[12]. In an observational study of patients during car-
diopulmonary bypass in cardiac surgery, the duration
and degree to which MAP was below the cerebral
Fig. 2 Comparison of % parameter deficits between patients with progression of AKI (AKI+) and without progression of AKI (AKI–). AKI acute
kidney injury, AKI+ increase of at least one KDIGO stage shift, AKI– no KDIGO stage shift, CVP central venous pressure, DAP diastolic arterial pressure,
DPP diastolic perfusion pressure, KDIGO Kidney Disease: Improving Global Outcomes, MAP mean arterial pressure, MPP mean perfusion pressure,
SAP systolic arterial pressure
Fig. 3 Hemodynamic deficit change during the first 24 hours of vasopressor support. Diastolic arterial pressure (DAP) deficit, mean perfusion
pressure (MPP) deficit, and diastolic perfusion pressure (DPP) deficit for AKI+ (solid lines) and AKI– (dashed lines), respectively. Data are median
values. AKI acute kidney injury, AKI+ increase of at least one KDIGO stage shift, AKI– no KDIGO stage shift, KDIGO Kidney Disease: Improving
Global Outcomes
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autoregulation threshold was independently associated
with AKI, but absolute MAP was not [13]. To the best of
our knowledge, there are only two previous studies that
evaluated the impact of changes from the premorbid BP
level on subsequent AKI development or progression in
critically ill patients with shock [3, 14]. One observational
study comprised 51 consecutive heterogeneous patients
requiring vasopressors and compared premorbid MPP
estimated from premorbid BP and CVP with MPP during
resuscitation [3]. The incidence of AKI progression was
greater among patients with greater MPP deficits. The
other observational study comprised 107 patients with
septic shock and investigated the association of change
from premorbid values with AKI progression [14].
Median MAP deficit was similar for patients with or
without severe AKI; however, median MPP deficit was
greater in patients with severe AKI. These results are
consistent with those found in the present study.
We observed a greater DAP deficit (P = 0.027) and DPP
deficit (P = 0.002) in the AKI+ group. We also observed a
lower CVP deficit in the AKI+ group (P = 0.033). A recent
retrospective study of 137 septic patients in the ICU
showed associations between lower DAP or higher CVP
and AKI but not between MAP or cardiac output and
AKI [5]. The present study is the first to report an associ-
ation between changes from premorbid DAP and AKI
progression. In the present study, 23.8 % of the %DPP
deficit was due to an increase in CVP, and 76.2 % was due
to a decrease in DAP. These results suggest that a role of
both DAP and back pressure (renal venous pressure) are
potentially important in the development of AKI.
Study implications
Previous studies have reported an association between
greater premorbid MAP and a shift of the kidney’s auto-
regulatory range to the right [15]. Our present results
imply that the autoregulation of renal blood flow may
be more strongly affected by MPP and DPP than MAP
because premorbid MPP and DPP were higher in AKI+
group but premorbid MAP was similar between groups.
Particularly, deficit in diastolic perfusion may be the
major factor responsible for decreased renal perfusion
and function. Because renal vascular resistance is low,
as evidenced by a positive diastolic blood flow velocity
[16, 17], DPP might be a key determinant of renal perfu-
sion. This raises the possibility that increasing diastolic
blood flow and decreasing back-pressure determinants
(CVP or renal venous pressure) may be important future
targets for hemodynamic manipulation in these patients.
This study could not assess a causal relationship be-
tween hemodynamic parameter deficits and AKI pro-
gression. Further studies are needed to clarify whether
it is possible to prevent subsequent AKI progression
with hemodynamic interventions, and what would be
the targets of DAP, MPP and DPP deficits.
Study strengths and limitations
This is the first study to investigate changes from pre-
morbid to in-ICU levels of key pressures in patients with
shock after cardiovascular surgery and the first to identify
which hemodynamic parameters differ in patients who
develop AKI progression. We focused on patients who
had undergone cardiovascular surgery for whom we could
estimate premorbid CVP accurately according to pre-
operative echocardiography. In addition, this is the first
study to demonstrate the importance not only of MPP
deficit but also of DPP deficit as possible risk factors for
subsequent deterioration of renal function.
There are several limitations in the present study.
First, this was single center in design, with a small sam-
ple size. We excluded patients who stayed in the ICU for
shorter than 48 hours, since our study design required a
long observational period, enough to diagnose AKI pro-
gression. We also excluded patients who received mech-
anical cardiovascular support (ECMO or IABP), to avoid
the impact of mechanical support on renal perfusion.
However, we believe that such exclusion made our study
patients more homogenous to study an association be-
tween systemic hemodynamics and AKI progression in
patients receiving vasopressors. However, the incidence of
AKI and outcomes in patients in our ICU are consistent
with those of studies reporting the epidemiology of AKI in
patients undergoing cardiovascular surgery [18, 19]. The
sample size of our study was larger than that of the only
previous study of patients with nonspecific shock [3]. In
addition, the median achieved MAP of 74 mm Hg in
our study patients was quite similar to that reported
among vasopressor-dependent septic shock patients in
the previous major randomized trial [20] and in a re-
cent observational study of the association between sys-
tematic hemodynamics and septic AKI [5]. The median
achieved CVP of 8 mm Hg was also the same as the
lower limit level recommended in the current guide-
lines for septic shock [21] and slightly lower than that
reported in a recent randomized trial of early goal-
directed therapy [22].
It is unclear whether the methods of BP and CVP esti-
mation used in the present study represent true premor-
bid BP and CVP values. However, we estimated baseline
CVP by using inferior vena cava parameters according
to the American Society of Echocardiography guidelines
[7]. This approach might make the premorbid CVP
value more accurate than that reported in previous studies
[3, 14]. Finally, we studied only a cohort of patients with
shock after cardiovascular surgery. Therefore, our findings
may not apply to patients with shock due to other types of
critical illness.
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Conclusions
We found that despite equivalent unadjusted MAP, DAP,
and MPP values, vasopressor-dependent patients who
had undergone cardiovascular surgery with AKI progres-
sion had greater DAP, MPP, and DPP deficits compared
to patients without AKI progression. These results suggest
that deficits of DAP, MPP, and DPP might be considered
as adjustable target hemodynamic parameters to prevent
subsequent AKI progression. In addition, our findings
suggest the need to further investigate the relation be-
tween diastolic perfusion and AKI progression in patients
with circulatory shock.
Key messages
 Deficits of DAP, MPP, and DPP might be considered
as adjustable target hemodynamic parameters to
prevent subsequent AKI progression.
 There is the need to further investigate the relation
between diastolic perfusion and AKI progression in
patients with circulatory shock.
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